This inventor holds 1 USPTO granted patent. Top assignee: Fast Forward Pharmaceuticals B.v.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Kevin Stuart Johnson: Innovator in Monoclonal Antibody Development
Introduction
Kevin Stuart Johnson is a notable inventor based in Herts, GB. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that have the potential to impact therapeutic applications.
Latest Patents
Kevin holds a patent for an antagonistic anti-human CD40 monoclonal antibody. This invention provides novel antagonistic anti-human CD40 monoclonal antibodies, methods for generating them, and various uses thereof. His patent represents a significant advancement in the field of immunology.
Career Highlights
Kevin is currently associated with Fast Forward Pharmaceuticals B.V., where he continues to work on groundbreaking research and development projects. His expertise in monoclonal antibodies positions him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues, including Ruprecht Jules Joost Van Neerven and Robert Duncan Casson. These partnerships have fostered innovation and contributed to the advancement of their shared research goals.
Conclusion
Kevin Stuart Johnson is a distinguished inventor whose work in monoclonal antibodies exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile